𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma

✍ Scribed by Janos Geli; Per Kogner; Fredrik Lanner; Natalia Natalishvili; Christofer Juhlin; Nimrod Kiss; Geoffrey J. Clark; Tomas J. Ekström; Filip Farnebo; Catharina Larsson

Publisher
John Wiley and Sons
Year
2008
Tongue
French
Weight
250 KB
Volume
123
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The putative tumor suppressor NORE1A (RASSF5) is a member of the Ras association domain family and is commonly inactivated in human cancer. The closely related gene family member and functional collaborator RASSF1A is a bona fide tumor suppressor and is frequently involved in neuroblastoma. In the present study, we sought to investigate the role of NORE1A in human neuroblastoma. A panel of tumors (36 neuroblastomas and 4 ganglioneuromas) and neuroblastoma cell lines was assessed for NORE1A gene expression by Taqman quantitative RT‐PCR. Promoter methylation was quantitatively determined by methylation sensitive pyrosequencing. The antitumourigenic role was functionally investigated in Nore1a transfected SK‐N‐BE (2) cells by fluorescent inhibition of caspase activity and BrdU incorporation assays. Neuroblastoma cells showed very low or absent NORE1A mRNA expression, which could not be reversed by trichostatin A or 5‐aza‐cytidine treatments. Neuroblastoma tumors showed suppressed NORE1A gene expression that was particularly pronounced in cases without MYCN amplification or 1p loss. Methylation of the NORE1A promoter was not observed in primary tumors and only one out of seven neuroblastoma cell lines displayed weak partial methylation. Transient expression of Nore1a resulted in enhanced apoptosis and delayed cell cycle progression. In conclusion NORE1A appears to be strongly suppressed in neuroblastic tumors and reconstitution of its expression diminishes the tumorigenic phenotype. Promotor methylation is not a common mechanism responsible for NORE1A transcriptional suppression in this tumor type. © 2008 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Sublocalization of putative tumor suppre
Sublocalization of putative tumor suppressor gene loci on chromosome arm 14q in neuroblastoma
✍ Marco Theobald; Holger Christiansen; Anke Schmidt; Badrig Melekian; Nicole Wolke 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 2 views

RFLP and microsatellite analysis with 23 polymorphic markers spanning the entire long arm of chromosome 14 in 108 neuroblastomas showed allelic loss in 19 out of 107 (18%) informative tumors, placing 14q among the most frequently affected chromosomal regions in neuroblastoma. One minimal deletion re

Characterization of C4-2 as a tumor-supp
Characterization of C4-2 as a tumor-suppressor gene in human brain tumors
✍ Sehgal, Anil; Keener, Cassie; Boynton, Alton L.; Young, Ronald F.; Vermeulen, Sa 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 3 views

Background: Brain tumors claimed the lives of 13,300 people in 1995. Our objective was to isolate and characterize unique tumor-suppressor genes from human brain tumors derived from patients in the United States. Methods: Differential display-polymerase chain reaction was used to isolate tumor suppr

The role of PGP9.5 as a tumor suppressor
The role of PGP9.5 as a tumor suppressor gene in human cancer
✍ Yutaka Tokumaru; Keishi Yamashita; Myoung Sook Kim; Hannah L. Park; Motonobu Osa 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 386 KB 👁 2 views

## Abstract PGP9.5 is a controversial molecule from an oncologic point of view. We recently identified frequent methylation of PGP9.5 gene exclusively in primary head and neck squamous cell carcinoma (HNSCC), suggesting that it could be a tumor suppressor gene. On the other hand, PGP9.5 was reporte

Genetic mapping of a putative tumor supp
Genetic mapping of a putative tumor suppressor locus that influences tumorigenesis and metastasis in mice
✍ Bernard Ayanga; Roger Price; Xiangjun Gu; Guillermina Lozano; Susan C. Evans 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB 👁 1 views

## Abstract The tumor suppressor __TP53__ is mutated in ∼70% of Li‐Fraumeni syndrome (LFS) families; however, other genes may lead to the predisposition to tumors in other families. We developed a mouse model to search for other tumor suppressors that may be involved in the syndrome. Inbred CE/J mi